Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

MLA

Elmariah, Sammy, et al. “Extended Duration Dual Antiplatelet Therapy and Mortality: A Systematic Review and Meta-Analysis.” Lancet (London, England), vol. 385, no. 9970, Feb. 2015, pp. 792–98. EBSCOhost, https://doi.org/10.1016/S0140-6736(14)62052-3.

APA

Elmariah, S., Mauri, L., Doros, G., Galper, B. Z., O’Neill, K. E., Steg, P. G., Kereiakes, D. J., & Yeh, R. W. (2015). Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis. Lancet (London, England), 385(9970), 792–798. https://doi.org/10.1016/S0140-6736(14)62052-3

Chicago

Elmariah, Sammy, Laura Mauri, Gheorghe Doros, Benjamin Z Galper, Kelly E O’Neill, Philippe Gabriel Steg, Dean J Kereiakes, and Robert W Yeh. 2015. “Extended Duration Dual Antiplatelet Therapy and Mortality: A Systematic Review and Meta-Analysis.” Lancet (London, England) 385 (9970): 792–98. doi:10.1016/S0140-6736(14)62052-3.